Following up on the great work by Steppenwolf, I just posted this on the street's article by Janet Guyon:
I would like your take on your non biased, veteran reporter
Adam Feuerstein’s positively glowing article on Bluebird Bio dated 06/14/14 titled, “Blood Disorder Patients Respond Strongly to Bluebird Bio Gene Therapy.” Striking results on two patients? Wow, two patients constitutes striking results?
I would like to refer to the PR release by NWBO on 06/11/14
updating early results of their DCVax Direct trial titled, “DCVax-Direct Trial Update Indicates Further Positive Responses; 3 Case Studies Show No Live Tumor Cells In Injected Tumors.” In this PR, early data is given on 20 patients in the trial with very encouraging and positive results being shown. Wouldn’t this warrant a positive article by your savvy, unbiased, veteran biotech reporter? Guess not…instead he went on the attack again and he has time and time again when NWBO announces any positive PR’s.
Back to Bluebird Bio. It’s ironic that Bluebird Bio’s PR Company
is Pure Communications, Inc. and their VP of Media Relation is Dan Budwick. Why is this ironic? Well, here is a tweet on September 28, 2014 by your unbiased, veteran reporter Adam Feuerstein: “Lovely way to spend day with my friend and fellow Yankees fan @DanBudwick. Thank you, Captain. #2.” Followed by another tweet, ! @adamfeuerstein earns Red Sox tix w/ @DanBudwick after promoting Bluebird, Celldex & other Pure client’s @jimcramer.
Now I see where you are coming from Janet in defending your
unbiased, veteran reporter Adam Feuerstein. He obviously is a very ethical reporter who has no bias in any of his articles.
I certainly look forward to your response on this as well as
your response on the disingenuous statement you made regarding NWBO’s interim
analysis.
